Navigation Links
Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2013 On February 4, 2013
Date:1/29/2013

BOULDER, Colo., Jan. 29, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:   ARRY) will report financial results for the second quarter of fiscal 2013 on Monday, February 4, 2013, and will hold a conference call on Tuesday, February 5, 2013 at 9:00 a.m. eastern time to discuss these results.  Ron Squarer, Chief Executive Officer and Michael Carruthers , Chief Financial Officer will lead the call.

Conference Call InformationDate:Tuesday, February 5, 2013Time:9:00 a.m. eastern timeToll-Free:(800) 447-0521Toll:(847) 413-3238Pass Code:34113160Webcast & Conference Call Slides:  http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhomeA replay of the call will be available as a webcast on www.arraybiopharma.com About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company with significant progress toward generating data to support our upcoming Phase 3 / pivotal trial decisions.  Array-invented MEK162 will be tested in a Phase 3 trial in NRAS melanoma in the next several months as well as BRAF mutant melanoma later in 2013 (with Novartis).  Four other Array invented drugs are also approaching Phase 3 decisions by the end of calendar year 2013.  These include Array's wholly owned drugs, ARRY-614 and ARRY-520, and two additional partnered programs, selumetinib (with AstraZeneca) and danoprevir (with InterMune / Roche).  For more information on Array, please go to www.arraybiopharma.com.


'/>"/>
SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Bar Harbor BioTechnology to Offer Direct Sales Starting in 2013; Development of StellARrays™ for C.elegans and Zebrafish Underway
2. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
3. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
4. John A. Orwin Joins Array BioPharma Board Of Directors
5. Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor
6. Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts
7. Solar nanowire array may increase percentage of suns frequencies available for energy conversion
8. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
9. Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray
10. Self-assembling nanorods: Berkeley Lab researchers obtain 1-, 2- and 3-D nanorod arrays and networks
11. Maine Manufacturing, LLC Announces Global Distribution of FAST® Protein Array Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... 2017 , ... Having proven that its Disruptor™ technology is ... Green Cell Technologies® (GCT®), has turned its attention to the lucrative ... ‘pressing’ methods, ushering in a new era of modern, cost effective and more ...
(Date:8/22/2017)... ... August 22, 2017 , ... One of the biggest ... of opioid-dose sparing. Opioid-dose sparing refers to the reduction of opioid dosage by ... anti-inflammatory drugs (NSAIDs). , The potential for new therapies to replace opioids and/or ...
(Date:8/21/2017)... ... August 21, 2017 , ... Baltimore biotech firm, PathSensors, ... to bring its proprietary CANARY pathogen detection technology and high throughput testing solutions ... has purchased an undisclosed number of PathSensors’ Zephyr pathogen detection instruments and will ...
(Date:8/18/2017)... San Jose, CA (PRWEB) , ... August 18, ... ... of advanced precision Lithography Equipment for the Semiconductor, MEMS, and Microfluidics Industries, announces ... offers features and specifications found more often in automated production mask aligners. OAI ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
(Date:3/23/2017)... report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), Product ... by MarketsandMarkets, the market is expected to be worth USD 18.98 billion by ... Continue Reading ... ...      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
Breaking Biology News(10 mins):